Welcome to our dedicated page for McKesson news (Ticker: MCK), a resource for investors and traders seeking the latest updates and insights on McKesson stock.
McKesson Corporation (MCK) delivers vital healthcare supply chain solutions through pharmaceutical distribution, medical-surgical product management, and technology services. This page provides investors and industry observers with direct access to McKesson's official news updates and market-moving developments.
Track earnings announcements, strategic partnerships, and regulatory filings alongside operational milestones shaping McKesson's role in healthcare logistics. Our curated feed consolidates press releases and verified news to help stakeholders monitor the company's performance in pharmaceutical wholesale and healthcare IT innovation.
Discover updates on McKesson's supply chain optimization initiatives, technology platform enhancements, and collaborations with hospitals, pharmacies, and manufacturers. Bookmark this page for efficient monitoring of developments impacting one of North America's leading healthcare distribution networks.
McKesson Corporation (NYSE: MCK) announced its fiscal 2022 fourth-quarter financial results, which are accessible through its Investor Relations website. A live webcast of the earnings conference call is scheduled for May 5 at 4:30 PM ET, allowing investors to review the results in detail. McKesson aims to enhance healthcare accessibility and affordability through partnerships with various healthcare entities. More information is available on their official website.
AmerisourceBergen (ABC), Cardinal Health (CAH), and McKesson (MCK) have settled opioid-related claims with the Washington Attorney General, agreeing to pay up to $518 million. This payment resolves lawsuits filed by the state and its subdivisions, allowing for the dismissal of ongoing litigation. The settlement aligns with a previously announced agreement effective April 2, 2022, aimed at addressing a significant portion of opioid claims against the distributors. The companies dispute the allegations but see this as steps toward broader resolutions and relief for impacted communities.
The Board of Directors of McKesson Corporation (NYSE:MCK) has declared a regular dividend of 47 cents per share of common stock. This dividend will be payable on July 1, 2022, to stockholders of record on June 1, 2022. McKesson Corporation is a leader in healthcare services, focusing on enhancing health outcomes through partnerships with various stakeholders in the industry, including biopharma companies and care providers. For further information, visit McKesson.com.
McKesson Corporation (NYSE: MCK) has successfully closed the sale of its UK businesses to AURELIUS, enhancing its focus on streamlining operations and exiting the European market.
The company is set to report its fourth quarter fiscal 2022 financial results on May 5, 2022, with a live earnings conference call at 4:30 PM ET. Further comments on the sale will be provided during this call, with the earnings release and financial details accessible on McKesson's Investor Relations website.
McKesson Corporation (NYSE: MCK) announced the election of W. Roy Dunbar as a new director and member of the Audit and Governance Committees, effective April 1, 2022. This expands the board from 11 to 12 members, with 11 being independent. Dunbar brings extensive experience from roles at Network Solutions, Mastercard, and Eli Lilly, focusing on technology, operations, and sustainability. His addition is expected to enhance the board's oversight, particularly in oncology, biopharma, data governance, and cybersecurity.
Settlement Announcement: AmerisourceBergen (ABC), Cardinal Health (CAH), and McKesson (MCK) have reached an agreement to settle the majority of opioid lawsuits with participation from 46 of 49 eligible states and over 90% of litigating political subdivisions. The settlement totals approximately $19.5 billion to be distributed over 18 years, with individual contributions of $6.1 billion, $6.0 billion, and $7.4 billion from AmerisourceBergen, Cardinal Health, and McKesson, respectively. The agreement aims to provide relief to communities affected by the opioid crisis.
McKesson Corporation (NYSE: MCK) announced its fiscal 2022 third-quarter financial results. Investors can access detailed results through the company's Investor Relations website. A live webcast of the earnings conference call will be held on February 2 at 4:30 PM ET, where management will discuss financial performance. McKesson has been recognized as a leading healthcare supply chain management provider and is noted for its commitment to patient health through innovative healthcare solutions.
The Board of Directors of McKesson Corporation (NYSE:MCK) declared a regular dividend of 47 cents per share, set for payment on April 1, 2022, to stockholders of record on March 1, 2022. McKesson, a leader in healthcare supply chain management, emphasizes its commitment to providing essential healthcare services. Recognized as a top company in various categories, McKesson continues to enhance its reputation and investor confidence through consistent dividend payments.
McKesson Corporation (NYSE: MCK) announced the election of James H. Hinton and Kathleen Wilson-Thompson as new board directors on Jan. 13, 2022, increasing the board from 9 to 11 members. Hinton, an operating partner at Welsh, Carson, Anderson & Stone, previously served as CEO of Baylor Scott & White Health, while Wilson-Thompson was EVP and global chief human resources officer at Walgreens Boots Alliance. Their extensive healthcare leadership experience is expected to strengthen McKesson's governance and strategic direction.
McKesson Corporation (NYSE: MCK) will announce its third quarter fiscal 2022 financial results on February 2, 2022, after market close. A live webcast will follow at 4:30 PM ET to discuss the results. McKesson will also participate in the 40th Annual J.P. Morgan Healthcare Conference on January 11, 2022. Investors can access the webcast and related financial information on McKesson’s Investor Relations website.
